The multicenter clinical study of the Sonablate for the treatment of locally recurrent prostate cancer with HIFU has locations throughout the United States and Canada. Below is a list of all the cities with physicians enrolling patients for the study. For more specific information on locations and the physicians involved in the trial, please click here.

United States
Birmingham, AL
Los Angeles, CA
Washington, D.C.
Naples, FL
New York, NY
Madison, WI
Myrtle Beach, SC
Cleveland, OH
Des Moines, IA
Jeffersonville, IN
Nashville, TN
Bala Cynwyd, PA
Bronx, NY
Baltimore, MD
Indianapolis, IN
New Haven, CT
Philadelphia, PA
Chicago, IL
New Orleans, LA
Durham, NC

Canada
Toronto, ON
London, ON
Winnipeg, MB